Given both our corporate and personal consulting backgrounds, we have a long history working effectively with executives
and teams across multiple therapeutic areas to develop, file and market biopharmaceutical products.
Broad Experience with Many Companies, Therapeutic Areas, and Products
|
Therapeutic Areas & Products
|
De Young & Hayden, LLC (DYH)
|
Adolor, ALZA, Berlex, BMS, CAT, Cell Genesys, CVT, DSM, IDEC,Innomab, Nektar,PDL, Pharmacia/Upjohn,
Pfizer,Regenesis, Roche, Danofi, Scios, Sepracor, Syntex, TMC, Tularik

Arthritic Disease/ Oncology
|
|
- Actemra
- Bondronat
- Mabthera/Rituxan
- Bonefos
- anti-CD5 &
- anti-CD22 monoclonal antibodies
|
|
- targeted antibodies
- anti-emetics
- drugs for hematological cancer
- drugs for solid tumors,
- drugs for ovarian cancer
- interleukin antagonists
|
|
|
- Flunisolide
- PDE IV inhibitors
- Xopenex, Spiriva
|
|
- COPD
- ARDS
- elastase inhibitors
|
|
Cardiovascular & Neurovascular
|
|
- Angiomax
- Clevelox
- Cangrelor
- Bostentan
- Posicor
- Ranexa
|
|
- Regadenoson
- Natrecor
- platelet antagonists
- thrombolytics
- cardioprotection
- Glyt1 transporter inhibitor & Alpha 7 nicotinic
acetylcholine receptor partial agonist
|
|
|
- Alzheimer's Disease
- Schizophrenia
- Depression
- Multiple sclerosis
|
|
- monoclonal antibodies
- transport inhibitors
- receptor agonists
|
|
|
- Accutane
- Alitretinoin
- Lidex
- apoptosis inhibitors
|
|
- anti-psoriatics
- anti-acne
- hair growth
|
|
|
- transdermal patches
- needle-less injectors
- topical formulations
|
|
- polymers
- patient controlled analgesia
|
|
|
|
- drugs for Ulcerative Colitis/Crohn’s Disease
|
|
|
- Valganciclovir
- Entecavir
- Pegasys
- Tamiflu
|
|
- Therapeutic vaccines for HBV, HCV, HPV
- antisense
|
|
Metabolic Disorders including Diabetes
|
|
- Xenical
- insulin sensitizers
|
|
|
|
|
|
|
|
|
|
|
- inhalation devices
- opioids
|
|
|
|
|
Transplantation/ Immunology
|
|
|
- anti-allergy
- autoimmune diseases
|
|
|
- anti scarring
- diabetic ulcers
|
|
- antisense
- debridement enzymes
- Radio Frequency Energy (PRFE)
|
|
|